ClinicalTrials.gg
Sign In

Beijing QL Biopharmaceutical Co.,Ltd clinical trials

Also known as Quality Peptide.

The registry lists 13 studies whose lead sponsor is Beijing QL Biopharmaceutical Co.,Ltd. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 4, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Get an email when these change. Save the Beijing QL Biopharmaceutical Co.,Ltd studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Pipeline: 5 programmes

Each counted once: 5 with a study Beijing QL Biopharmaceutical Co.,Ltd leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 1 phase-3 programme — sign in to see them, free: with every programme, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Beijing QL Biopharmaceutical Co.,Ltd’s own registered studies; Beijing QL Biopharmaceutical Co.,Ltd’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programmes are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Beijing QL Biopharmaceutical Co.,Ltd’s studies test, most open studies first — 5 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

7 of Beijing QL Biopharmaceutical Co.,Ltd’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 4D
  3. 1J’27
  4. F
  5. M
  6. A
  7. 1M
  8. 1J
  9. J
  10. A
  11. S
  12. O
  13. N

All 7

Show 2 more

Add all 7 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 15, 2026.

Newly registered1

All 13 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now323%Not yet recruiting 2 · Recruiting 1
  • Under way, not recruiting538%
  • Completed538%

Phase

  • Phase 19
  • Phase 24
  • Phase 31

Where

  • China12
  • Australia1

Over the years

  1. 23
  2. 24
  3. 25
  4. 626

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Beijing QL Biopharmaceutical Co.,Ltd.

  • Beijing QL Biopharmaceutical Co.,Ltd
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    13 studies

Focus areas

Conditions Beijing QL Biopharmaceutical Co.,Ltd leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Obesity10

Studies

Recruiting first, then most recently updated. Showing 13 of 13.